Table 1.
Clinical characteristics of participants with NASH or NAFL (N = 91).
| Parameter | NAFL (n = 46) | NASH (n = 45) | P |
|---|---|---|---|
| Sex | |||
| M | 35 | 32 | 0.764 |
| F | 11 | 13 | |
| Age (years) | 40.67 ± 11.34 | 35.87 ± 9.97 | 0.040* |
| BMI (kg/m2) | 24.72 ± 2.50 | 27.59 ± 2.33 | 0.001* |
| ALT (U/L) | 53.00 (34.43, 91.15) | 78.80 (51.80, 98.75) | 0.028* |
| AST (U/L) | 36.30 (25.25, 55.10) | 41.50 (30.50, 57.35) | 0.074 |
| AST/ALT | 0.66 (0.49, 0.90) | 0.57 (0.46, 0.78) | 0.184 |
| GGT (U/L) | 45.00 (24.53, 69.80) | 51.40 (29.75, 94.65) | 0.289 |
| ALP (U/L) | 74.06 ± 22.98 | 78.64 ± 28.82 | 0.275 |
| GLU (mmol/L) | 5.45 ± 1.46 | 5.71 ± 1.51 | 0.296 |
| TG (mmol/L) | 3.59 ± 3.83 | 2.48 ± 2.05 | 0.264 |
| ALB (g/L) | 48.26 ± 3.44 | 49.10 ± 4.30 | 0.067 |
| PLT (×109/L) | 213.67 ± 53.92 | 244.21 ± 60.93 | 0.023* |
| NAFLD fibrosis score | 5.65 ± 0.76 | 6.83 ± 0.99 | 0.036* |
Data are counts or mean ± standard deviation. * P < 0.05 vs. the NAFL group. Data were analysed using Student’s t-test, the Mann–Whitney U-test, the Kruskal–Wallis H-test or the chi-square test, as appropriate.
NAFL(D): non-alcoholic fatty liver (disease); NASH: non-alcoholic steatohepatitis; BMI: body mass index; ALT: alanine aminotransferase activity; AST: aspartate aminotransferase activity; GGT: gamma glutamyl transferase activity; ALP: alkaline phosphatase activity; GLU: glucose; TG: triglyceride; ALB: albumin; PLT: platelet count.